By Ameet Sarpatwari, Alexander Egilman, Aviva Wang, and Aaron S. Kesselheim
Every month, members of the Program On Regulation, Therapeutics, And Legislation (PORTAL) evaluation the peer-reviewed medical literature to establish attention-grabbing empirical research, coverage analyses, and editorials on well being regulation and coverage points.
Under are the citations for papers recognized from the month of September. The alternatives characteristic subjects starting from an examination of Park doctrine prosecutions of executives of pharmaceutical and medical gadget firms, an evaluation of patent thickets overlaying biologic medicine, and a dialogue of product hopping methods amongst producers of inhalers. A full posting of abstracts/summaries of those articles could also be discovered on our web site.
- Daval CJR, Avorn J, Kesselheim AS. Holding Pharmaceutical and Medical Gadget Executives Accountable as Accountable Company Officers. JAMA Intern Med. 2022 Sep 19. Epub forward of print.
- Feldman WB, Bloomfield D, Beall RF, Kesselheim AS. Model-name market exclusivity for nebulizer remedy to deal with bronchial asthma and COPD. Nat Biotechnol. 2022 Sep;40(9):1319-1325.
- Goode R, Chao B. Organic patent thickets and delayed entry to biosimilars, an American downside. J Legislation Biosci. 2022 Sep 1;9(2):lsac022.
- Kapczynski A. The Political Financial system of Market Energy in Prescribed drugs. J Well being Polit Coverage Legislation. 2022 Sep 27:10234184. Epub forward of print.
- Messinger JC, Kesselheim AS, Vine SM, Fischer MA, Barenie RE. Associations Between Copays, Protection Limits for Naloxone, and Prescribing in Medicaid. Subst Abuse. 2022 Sep 29;16:11782218221126972.
- Olivier T, Haslam A, Prasad V. Dose modification guidelines and availability of progress issue assist: A cross-sectional examine of head-to-head most cancers trials used for US FDA approval from 2009 to 2021. Eur J Most cancers. 2022 Sep;172:349-356. Epub forward of print.
- Walia A, Haslam A, Prasad V. FDA validation of surrogate endpoints in oncology: 2005-2022. J Most cancers Coverage. 2022 Sep 22;34:100364. Epub forward of print.
- Wouters OJ, Feldman WB, Tu SS. Product Hopping within the Drug Trade – Classes from Albuterol. N Engl J Med. 2022 Sep 29;387(13):1153-1156. Epub forward of print.
The submit Month-to-month Spherical-Up of What to Learn on Pharma Legislation and Coverage appeared first on Invoice of Well being.
